<DOC>
	<DOCNO>NCT01541644</DOCNO>
	<brief_summary>Patients ask study multiple myeloma tingling , numbness pain take bortezomib ( velcade® ) . Patients diagnose multiple myeloma often take bortezomib ( velcade® ) . This research do find acupuncture reduce nerve pain , tingling , and/or numbness patient experience due bortezomib ( velcade® ) . Acupuncture medical technique insert thin needle `` energy point '' body aim restore health well-being . It use widely treat pain , low back pain nerve pain . In study see acupuncture use ease nerve pain tingling , numbness cause bortezomib .</brief_summary>
	<brief_title>1068GCC Evaluate Efficacy &amp; Explore Mechanism Acupuncture Treating Bortezomib-induced Peripheral Neuropathy ( BIPN ) Multiple Myeloma</brief_title>
	<detailed_description>Information gain clinical trial provide insight efficacy mechanism acupuncture reduce Bortezomib-induced Peripheral Neuropathy ( BIPN ) multiple myeloma patient . It examine effect acupuncture serum proinflammatory cytokine β-endorphin level understand mechanism acupuncture molecular level . This study first clinical trial study effect acupuncture treat BIPN . It also first study explore mechanism acupuncture frequent small amount blood draw six time point detect change proinflammatory cytokine β-endorphins . It potential identify minimal risk non-pharmacological intervention alleviate BIPN symptom , significantly improve understand mechanism acupuncture .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Bortezomib</mesh_term>
	<criteria>Documented diagnosis multiple myeloma . Greater equal grade 2 BIPN define National Cancer Institute Common Toxicity Criteria ( NCICTC ) 4.0 . BIPN symptom persist bortezomib discontinue . Eastern Cooperative Oncology Group ( ECOG ) performance status 03 . Men woman ≥ 18 year old The patient aware nature diagnosis , understand study regimen , requirement , risk , discomfort , able willing sign inform consent form . Prior acupuncture within past month . Life expectancy &lt; 3 month . Plan go experimental drug multiple myeloma know cause peripheral neuropathy next 14 week . Concomitant treatment chemotherapy , unless approval give Principal Investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Acupuncture Therapy</keyword>
	<keyword>bortezomib-induced peripheral neuropathy</keyword>
</DOC>